Top compounds associated with response to DYRK2


Feature Type Standardized
Nominal ANOVA
mRNA 17-AAG GDSC1000 pan-cancer AAC -0.18 1e-08
mRNA Docetaxel GDSC1000 pan-cancer AAC -0.16 2e-07
mRNA darinaparsin CTRPv2 pan-cancer AAC 0.25 1e-06
mRNA temsirolimus GDSC1000 pan-cancer AAC -0.15 6e-06
mRNA BX-912 GDSC1000 pan-cancer AAC 0.13 2e-05
mRNA Elesclomol GDSC1000 pan-cancer AAC -0.14 3e-05
mRNA tubastatin A GDSC1000 pan-cancer AAC 0.12 6e-05
mRNA GSK1070916 GDSC1000 pan-cancer AAC 0.12 7e-05
mRNA XMD13-2 GDSC1000 pan-cancer AAC 0.12 0.0001
mRNA AUY922 GDSC1000 pan-cancer AAC -0.13 0.0002
Download CSV